Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.

× No keyword cloud information.

8 in total

1. Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

Authors: Truc T Tran; Siraya Jaijakul; Cole T Lewis; Lorena Diaz; Diana Panesso; Heidi B Kaplan; Barbara E Murray; Audrey Wanger; Cesar A Arias
Journal: Antimicrob Agents Chemother Date: 2012-03-26 Impact factor: 5.191

2. Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin.

Authors: Luis A Marcos; Bernard C Camins
Journal: Antimicrob Agents Chemother Date: 2010-09-27 Impact factor: 5.191

3. In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure.

Authors: Abrar K Thabit; David P Nicolau; Joseph L Kuti
Journal: Antimicrob Agents Chemother Date: 2015-10-19 Impact factor: 5.191

4. Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.

Authors: Truc T Tran; Vincent H Tam; Barbara E Murray; Cesar A Arias; Kavindra V Singh
Journal: Antimicrob Agents Chemother Date: 2017-05-24 Impact factor: 5.191

Review 5. Update on the emerging role of telavancin in hospital-acquired infections.

Authors: Obinna N Nnedu; George A Pankey
Journal: Ther Clin Risk Manag Date: 2015-04-13 Impact factor: 2.423

Review 6. Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus.

Authors: G Ralph Corey; Ethan Rubinstein; Martin E Stryjewski; Matteo Bassetti; Steven L Barriere
Journal: Clin Infect Dis Date: 2014-12-03 Impact factor: 9.079

Review 7. Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality.

Authors: Taohua Liu; Yuezhong Zhang; Qiquan Wan
Journal: Infect Drug Resist Date: 2018-05-03 Impact factor: 4.003

8. A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

Authors: Martin E Stryjewski; Arnold Lentnek; William O'Riordan; John Pullman; Paul Anantharajah Tambyah; Jose M Miró; Vance G Fowler; Steven L Barriere; Michael M Kitt; G Ralph Corey
Journal: BMC Infect Dis Date: 2014-05-23 Impact factor: 3.090

8 in total